Literature DB >> 856532

A comparison of the sensitivity and accuracy of the 99TCm-phosphate bone scan and skeletal radiograph in the diagnosis of bone metastases.

D L Citrin, R G Bessent, W R Greig.   

Abstract

The accuracy and sensitivity of the 99Tcm-phosphate bone scan and conventional skeletal radiology have been compared in 372 patients with documented malignant disease and 75 control subjects. Results indicate that the bone scan is a more sensitive method for the detection of skeletal metastases. The incidence of false-positive results with the bone scan is acceptably low. A protocol for the investigation of patients with suspected malignant disease of bone is suggested.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856532     DOI: 10.1016/s0009-9260(77)80137-2

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  13 in total

Review 1.  The use of radiation in the management of spinal metastases.

Authors:  C M Faul; J C Flickinger
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

2.  Bone scintigraphy, radiographic survey and prostatic acid phosphatase in patients with prostatic carcinoma. A comparison of sensitivity.

Authors:  O Reikerås; J Due; J A Sundsfjord
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

3.  Assessment of skeletal uptake of 99mTc-diphosphonate over a five day period.

Authors:  I Fogelman; W Martin
Journal:  Eur J Nucl Med       Date:  1983

4.  If I had...

Authors: 
Journal:  Br Med J       Date:  1978-05-06

5.  Improved lesion detection with dimethyl-amino-diphosphonate: a report of two cases.

Authors:  M L Smith; W Martin; J H McKillop; I Fogelman
Journal:  Eur J Nucl Med       Date:  1984

Review 6.  The role of skeletal scanning in clinical oncology.

Authors:  J H McKillop; I R McDougall
Journal:  Br Med J       Date:  1980-08-09

7.  A prospective study of bone tumor response assessment in metastatic breast cancer.

Authors:  Naoki Hayashi; Colleen M Costelloe; Tsuyoshi Hamaoka; Caimiao Wei; Naoki Niikura; Richard L Theriault; Gabriel N Hortobagyi; John E Madewell; Naoto T Ueno
Journal:  Clin Breast Cancer       Date:  2012-10-24       Impact factor: 3.225

8.  Diphosphonates in the evaluation of metabolic bone disease.

Authors:  I Fogelman; M L Smith
Journal:  Clin Rheumatol       Date:  1982-03       Impact factor: 2.980

Review 9.  Skeletal uptake of diphosphonate: a review.

Authors:  I Fogelman
Journal:  Eur J Nucl Med       Date:  1980-12

10.  Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer.

Authors:  T Hamaoka; C M Costelloe; J E Madewell; P Liu; D A Berry; R Islam; R L Theriault; G N Hortobagyi; N T Ueno
Journal:  Br J Cancer       Date:  2010-01-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.